Greg A. Krempl

Otolaryngology | Surgical Oncology | Plastic Surgery

800 NE 10th St Ste 4100
Oklahoma City, OK 73104

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Imaging-Detected Extranodal Extension in p16-Positive Oropharyngeal Cancer: Secondary Analysis of RTOG 1016.

Imaging-Detected Extranodal Extension in p16-Positive Oropharyngeal Cancer: Secondary Analysis of RTOG 1016.

Journal: JAMA otolaryngology-- head & neck surgery

Published: August 27, 2026

Developing an Interactive Human Papillomavirus Vaccination Education Program for Oropharyngeal Cancer Patients and Healthcare Providers: Lessons Learned from the Target Users' Feedback.

Developing an Interactive Human Papillomavirus Vaccination Education Program for Oropharyngeal Cancer Patients and Healthcare Providers: Lessons Learned from the Target Users' Feedback.

Journal: Vaccines

Published: June 10, 2026

Treatment Interruption and Outcomes in Head and Neck Cancer: A Secondary Analysis of 3 Randomized Clinical Trials.

Treatment Interruption and Outcomes in Head and Neck Cancer: A Secondary Analysis of 3 Randomized Clinical Trials.

Journal: JAMA otolaryngology-- head & neck surgery

Published: December 04, 2025

The KRAS-Variant and Cetuximab in HPV-Positive Oropharyngeal Cancer: Results from the NRG/RTOG 1016 Trial.

The KRAS-Variant and Cetuximab in HPV-Positive Oropharyngeal Cancer: Results from the NRG/RTOG 1016 Trial.

Journal: Cancer research communications

Published: October 21, 2025

Quality of Life in Patients With p16+ Oropharyngeal Cancer Receiving Accelerated Radiation Therapy With Either Cisplatin or Cetuximab in the NRG/RTOG 1016 Randomized Controlled Trial.

Quality of Life in Patients With p16+ Oropharyngeal Cancer Receiving Accelerated Radiation Therapy With Either Cisplatin or Cetuximab in the NRG/RTOG 1016 Randomized Controlled Trial.

Journal: International journal of radiation oncology, biology, physics

Published: August 28, 2025

Early Postoperative PTH Determination as Predictor for Post-Thyroidectomy Hypocalcemia.

Early Postoperative PTH Determination as Predictor for Post-Thyroidectomy Hypocalcemia.

Journal: International archives of otorhinolaryngology

Published: July 22, 2025

Increased Efficiency of Tumor Board With Introduction of the Consensus Slate.

Increased Efficiency of Tumor Board With Introduction of the Consensus Slate.

Journal: Ear, nose, & throat journal

Published: June 26, 2025

Impact of Anti-Fatigue Floor Mat on Surgical Staff Comfort Levels in Head and Neck Surgery Cases.

Impact of Anti-Fatigue Floor Mat on Surgical Staff Comfort Levels in Head and Neck Surgery Cases.

Journal: Laryngoscope investigative otolaryngology

Published: September 04, 2024

Self-Perceived Hearing Outcomes With Radiation and Cisplatin or Radiation and Cetuximab for Patients With Human Papilloma Virus (HPV)-Positive Oropharyngeal Cancer-Results From NRG Oncology RTOG 1016.

Self-Perceived Hearing Outcomes With Radiation and Cisplatin or Radiation and Cetuximab for Patients With Human Papilloma Virus (HPV)-Positive Oropharyngeal Cancer-Results From NRG Oncology RTOG 1016.

Journal: International journal of radiation oncology, biology, physics

Published: May 02, 2024

Occult neck metastasis in salvage laryngectomy: a road map for super-selective neck dissection.

Occult neck metastasis in salvage laryngectomy: a road map for super-selective neck dissection.

Journal: The Journal of laryngology and otology

Published: April 24, 2024

Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: an individual patient data meta-analysis.

Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: an individual patient data meta-analysis.

Journal: The Lancet. Oncology

Published: September 09, 2023

Tobacco cessation after head and neck cancer diagnosis is an independent predictor of treatment response and long-term survival.

Tobacco cessation after head and neck cancer diagnosis is an independent predictor of treatment response and long-term survival.

Journal: Oral oncology

Published: May 23, 2022

Showing 1-12 of 27

Last Updated: 09/26/2026